Literature DB >> 16513532

Identification of a novel mutation combination in factor XIII deficiency: genetic update to the first reported case in the United States.

Amy Halverstadt1, Sean Walsh, Stephen M Roth, Robert E Ferrell, James M Hagberg.   

Abstract

A 1967 report described the first known case of congenital factor XIII (FXIII) deficiency in the United States in a male patient with a severe hemorrhagic disorder. The patient's family presented no symptoms of the disorder, but the members were found to have half the normal FXIII activity. Although the molecular basis of the disorder could not be evaluated at the time, the results suggested an autosomal recessive inherited disorder. We sequenced all of the exons and the flanking regions in the genes for the FXIII A and B subunits of the patient, his family, and 18 unrelated individuals. We report the novel combination of an Arg-to-Cys mutation at codon 78 and a G-to-C mutation at the intron 5/exon 6 splice junction in the patient's FXIIIA gene. The missense-splice junction mutation combination appears to have caused the patient's FXIIIA deficiency, because the remaining family members, who present no symptoms and have no clinical diagnoses of FXIII deficiency, have one or the other of the 2 mutations but not both. Additionally, the 18 unrelated individuals are homozygous wild type at these loci. The molecular consequences of these mutations appear to be an abnormality in protein conformation or folding and/or a reduced production of messenger RNA transcripts of varying length that likely result in a nonfunctional, unstable FXIII protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513532     DOI: 10.1532/IJH97.NA0507

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  13 in total

Review 1.  Factor XIII deficiency.

Authors:  R Anwar; K J Miloszewski
Journal:  Br J Haematol       Date:  1999-12       Impact factor: 6.998

2.  Deficiency of factor XIII gene in Chinese: 3 novel mutations.

Authors:  Baohua Duan; Xuefeng Wang; Haiyan Chu; Yiqun Hu; Xiaping Huang; Bin Qu; Hongli Wang; Zhenyi Wang
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

3.  A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency.

Authors:  F DUCKERT; E JUNG; D H SHMERLING
Journal:  Thromb Diath Haemorrh       Date:  1960-12-15

4.  Splicing and missense mutations in the human FXIIIA gene causing FXIII deficiency: effects of these mutations on FXIIIA RNA processing and protein structure.

Authors:  R Anwar; L Gallivan; K J Miloszewski; A F Markham
Journal:  Br J Haematol       Date:  1998-11       Impact factor: 6.998

5.  Delayed umbilical bleeding--a presenting feature for factor XIII deficiency: clinical features, genetics, and management.

Authors:  Rashida Anwar; Adrian Minford; Louise Gallivan; Chi H Trinh; Alexander F Markham
Journal:  Pediatrics       Date:  2002-02       Impact factor: 7.124

6.  Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII.

Authors:  V C Yee; L C Pedersen; I Le Trong; P D Bishop; R E Stenkamp; D C Teller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

7.  Congenital deficiency of factor 13 (fibrin-stabilizing factor): Report of a case and review of the literature.

Authors:  A F Britten
Journal:  Am J Med       Date:  1967-11       Impact factor: 4.965

8.  Structure and function studies of factor XIIIa by x-ray crystallography.

Authors:  V C Yee; I Le Trong; P D Bishop; L C Pedersen; R E Stenkamp; D C Teller
Journal:  Semin Thromb Hemost       Date:  1996       Impact factor: 4.180

9.  Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA.

Authors:  H Mikkola; L Muszbek; E Laiho; M Syrjälä; E Hämäläinen; G Haramura; T Salmi; L Peltonen; A Palotie
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

10.  A point mutation in an invariant splice acceptor site results in a decreased mRNA level in a patient with severe coagulation factor XIII subunit A deficiency.

Authors:  P Vreken; R W Niessen; M Peters; M C Schaap; J G Zuithoff-Rijntjes; A Sturk
Journal:  Thromb Haemost       Date:  1995-08       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.